Skip to main content

Advertisement

Table 1 Average dosimetric data and plan evaluation parameters for the PTVs

From: Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer

Target Plans Prescription Inhomogeneity Conformity
Volumea D min b D max b D mean c p* IC p* CN p*
PSV-PPS Proton 99.0 % 96.3 % 175.1 % 69.3 <0.001 0.571 0.029 0.051 0.796
IMRT 96.6 % 158.7 % 63.7 0.491 0.054
PPS-PGTVs Proton 99.2 % 98.4 % 133.1 % 83.9 0.019 0.290 <0.001 0.328 0.143
IMRT 96.2 % 135.0 % 81.7 0.333 0.392
PGTVs Proton 98.7 % 99.3 % 104.0 % 91.6 <0.001 0.046 <0.001 0.216 <0.001
IMRT 97.8 % 107.9 % 93.9 0.097 0.358
  1. *p-value associated with the values to the left; significant values are bold
  2. aMinimum volume covered by the PD
  3. bRelative to PD (%); defined to 0.02 cc
  4. cin Gy